1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PARABILIS MEDICINES INC.
Parabilis Medicines Inc.
XNAS: PBLS
30.57 0.21 (0.69%)
664.3K
XNAS Volume

XNAS 10 Jul, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert



Insider Trading disclosures for Parabilis Medicines Inc

The latest disclosure was made by Alan M. Sebulsky in Parabilis Medicines Inc where a trade of 8,435 Common Stock done at an average price of $27.7 was reported to US exchanges on June 12, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Alan M. Sebulsky Director Purchase of securities on an exchange or from another person at price $ 27.67 per share. 12 Jun 2026 8,435 20,935 - 27.7 233,393 Common Stock
Alan M. Sebulsky Director Purchase of securities on an exchange or from another person at price $ 26.00 per share. 12 Jun 2026 5,000 25,935 - 26.0 129,989 Common Stock
Alan M. Sebulsky Director Purchase of securities on an exchange or from another person at price $ 27.10 per share. 12 Jun 2026 4,065 30,000 - 27.1 110,146 Common Stock
Alexis A. Borisy Director 11 Jun 2026 162,221 0 - - Series F Preferred Stock
Alexis A. Borisy Director 11 Jun 2026 105,414 105,414 - - Common Stock
Alan M. Sebulsky Director Purchase of securities on an exchange or from another person at price $ 20.00 per share. 11 Jun 2026 12,500 12,500 - 20 250,000 Common Stock
Edward M. Fitzgerald Director 09 Jun 2026 5,539 5,539 - - Common Stock
Edward M. Fitzgerald Director 09 Jun 2026 8,111 0 - - Series F Preferred Stock
Edward M. Fitzgerald Director 09 Jun 2026 3,666 0 - - Series C Preferred Stock
Edward M. Fitzgerald Director 09 Jun 2026 5,332 0 - - Series B Preferred Stock
Edward M. Fitzgerald Director 09 Jun 2026 5,271 14,688 - - Common Stock
Edward M. Fitzgerald Director 09 Jun 2026 3,878 9,417 - - Common Stock
Alexis A. Borisy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2026 20,215 20,215 - - Stock Option (Right to Buy)
Jake Simson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2026 20,215 20,215 - - Stock Option (Right to Buy)
Barbara L. Weber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2026 20,215 20,215 - - Stock Option (Right to Buy)
Krishna Yeshwant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2026 20,215 20,215 - - Stock Option (Right to Buy)
Edward M. Fitzgerald Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2026 20,215 20,215 - - Stock Option (Right to Buy)
Alan M. Sebulsky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2026 39,792 39,792 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures